| 2933.39.61 | 10 | 3-Quinuclidinyl benzilate | kg | | | |
| 2933.41.00 | 00 | Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2933.41.00 | 00 | Levorphanol (INN) and its salts | kg | Free | | 15.4¢/kg + 67.5% |
| 2933.49.08 | 00 | 4,7-Dichloroquinoline | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2¢/kg + 3.1% (SG) | 15.4¢/kg + 52% |
| 2933.49.10 | 00 | Ethoxyquin (1,2-Dihydro-6-ethoxy-2,2,4- trimethylquinoline) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¢/kg + 55% |
| 2933.49.15 | 00 | 8-Methylquinoline and Isoquinoline | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4¢/kg + 39.5% |
| 2933.49.17 | 00 | Ethyl ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylate | kg | Free | | 15.4¢/kg + 52% |
| 2933.49.20 | 00 | 5-Chloro-7-iodo-8-quinolinol (Iodochlorhydroxyquin); Decoquinate; Diiodohydroxyquin; and Oxyquinoline sulfate | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 46% |
| 2933.49.60 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 52% |
| 2933.52 | | Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: | | | | |
| 2933.52 | | Malonylurea (Barbituric acid) and its salts: | | | | |
| 2933.52.10 | 00 | Malonylurea (barbituric acid) | kg | Free | | 25% |
| 2933.53.00 | 00 | Allobarbital (INN), amobarbital (INN), barbital (INN), butalbital (INN), butobarbital, cyclobarbital (INN), methylphenobarbital (INN), pentobarbital (INN), phenobarbital (INN), secbutabarbital (INN), secobarbital (INN) and vinylbital (INN); salts thereof | kg | Free | | 50% |
| 2933.54.00 | 00 | Other derivatives of malonylurea (barbituric acid); salts thereof | kg | 3.7% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P, SG) | 50% |
| 2933.55.00 | 00 | Loprazolam (INN), mecloqualone (INN), methaqualone (INN) and zipeprol (INN); salts thereof | kg | Free | | 15.4¢/kg + 149.5% |
| 2933.59.21 | 00 | Antihistamines, including those principally used as anti-nauseants | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 82% |
| 2933.59.22 | 00 | Anti-infective agents: | | | | |
| 2933.59.22 | 00 | Nicarbazin; and Trimethoprim | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 46% |
| 2933.59.46 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4¢/kg + 149.5% |
| 2933.59.70 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 52% |
| 2933.59.85 | 00 | 2-Amino-4-chloro-6-methoxypyrimidine; 2-Amino-4,6-dimethoxypyrimidine; and 6-Methyluracil | kg | Free | | 30.5% |
| 2933.61.00 | 00 | Compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.61.00 | 00 | Melamine | kg | 3.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P,SG) | 25% |
| 2933.69.20 | 00 | 2,4-Diamino-6-phenyl-1,3,5-triazine | kg | Free | | 25% |
| 2933.69.60 | 10 | Cyanuric chloride | kg | | | |
Harmonized Tariff Schedule of the United States inquiry: ../
